Leading Biopharmaceutical Technology Surges Over 240% Intraday After Announcing Plans to Acquire Full Equity of Conflux

Odaily Planet Daily reported that Hong Kong-listed company Leading Pharma-Biotech (00399) saw a surge in trading volume and a sharp rise in its share price during early trading today, with an intraday increase of nearly 240% and a peak price of HK$0.7, before retreating to around HK$0.34.
Previously, the company announced plans to acquire all equity in the blockchain project Conflux to expand its presence in the blockchain sector. Two founding members of Conflux currently serve as its executive directors.